Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita Pye

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Expert Opinion on Investigational Drugs|September 26, 2019
Experimental and investigational drugs for the treatment of alpha-1 antitrypsin deficiencyAnita Pye, Alice M Turner
Advances in Therapy|February 12, 2026
Alpha-1 Antitrypsin Deficiency: Current Landscape of Detection, Management, and TreatmentRaunak Mawani, Anita Pye, Alice M Turner
Expert Opinion on Emerging Drugs|December 19, 2023
Are clinical trials into emerging drugs for the treatment of alpha-1 antitrypsin deficiency providing promising results?Joshua De Soyza, Anita Pye, Alice M Turner
Therapeutics and Clinical Risk Management|December 28, 2020
Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current PerspectivesMark Quinn, Paul Ellis, Anita Pye, et al.
Biomedicines|July 29, 2023
Predicting Lung Function Using Biomarkers in Alpha-1 Antitrypsin DeficiencyDaniella A Spittle, Alison Mansfield, Anita Pye, et al.
COPD|October 22, 2021
Relationship between Depression and Anxiety, Health Status and Lung Function in Patients with Alpha-1 Antitrypsin DeficiencyFarah Mobeen, Ross G Edgar, Anita Pye, et al.
Orphanet Journal of Rare Diseases|August 12, 2023
The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCORobert A Stockley, Anita Pye, Joshua De Soyza, et al.
ERJ Open Research|March 11, 2026
Optimising pulmonary rehabilitation for α<sub>1</sub>-antitrypsin deficiency: a qualitative study of patient and clinician perspectivesFawaz A Alwadani, Rachel Adams, Mohammed Alshahrani, et al.
Respiratory Medicine|March 5, 2025
Bacterial colonisation doubles the risk of exacerbation in alpha-1 antitrypsin deficiencyDaniella A Spittle, Anita Pye, Jan Stanka, et al.
Thorax|September 18, 2025
Pulmonary rehabilitation and quality of life in alpha-1 antitrypsin deficiency: findings from a retrospective cohort studyFawaz Alwadani, Paul R Ellis, Michael Newnham, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|September 26, 2019
Experimental and investigational drugs for the treatment of alpha-1 antitrypsin deficiencyAnita Pye, Alice M Turner
Advances in Therapy|February 12, 2026
Alpha-1 Antitrypsin Deficiency: Current Landscape of Detection, Management, and TreatmentRaunak Mawani, Anita Pye, Alice M Turner
Expert Opinion on Emerging Drugs|December 19, 2023
Are clinical trials into emerging drugs for the treatment of alpha-1 antitrypsin deficiency providing promising results?Joshua De Soyza, Anita Pye, Alice M Turner
Therapeutics and Clinical Risk Management|December 28, 2020
Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current PerspectivesMark Quinn, Paul Ellis, Anita Pye, et al.
Biomedicines|July 29, 2023
Predicting Lung Function Using Biomarkers in Alpha-1 Antitrypsin DeficiencyDaniella A Spittle, Alison Mansfield, Anita Pye, et al.
COPD|October 22, 2021
Relationship between Depression and Anxiety, Health Status and Lung Function in Patients with Alpha-1 Antitrypsin DeficiencyFarah Mobeen, Ross G Edgar, Anita Pye, et al.
Orphanet Journal of Rare Diseases|August 12, 2023
The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCORobert A Stockley, Anita Pye, Joshua De Soyza, et al.
ERJ Open Research|March 11, 2026
Optimising pulmonary rehabilitation for α<sub>1</sub>-antitrypsin deficiency: a qualitative study of patient and clinician perspectivesFawaz A Alwadani, Rachel Adams, Mohammed Alshahrani, et al.
Respiratory Medicine|March 5, 2025
Bacterial colonisation doubles the risk of exacerbation in alpha-1 antitrypsin deficiencyDaniella A Spittle, Anita Pye, Jan Stanka, et al.
Thorax|September 18, 2025
Pulmonary rehabilitation and quality of life in alpha-1 antitrypsin deficiency: findings from a retrospective cohort studyFawaz Alwadani, Paul R Ellis, Michael Newnham, et al.
Pageof 2